Literature DB >> 16831841

Development of a physiologically based pharmacokinetic model for deltamethrin in the adult male Sprague-Dawley rat.

Ahmad Mirfazaelian1, Kyu-Bong Kim, Sathanandam S Anand, Hyo J Kim, Rogelio Tornero-Velez, James V Bruckner, Jeffrey W Fisher.   

Abstract

Deltamethrin (DLT) is a type II pyrethroid insecticide widely used in agriculture and public health. DLT is a potent neurotoxin that is primarily cleared from the body by metabolism. To better understand the dosimetry of DLT in the central nervous system, a physiologically based pharmacokinetic (PBPK) model for DLT was constructed for the adult, male Sprague-Dawley rat that employed both flow-limited (brain, gastrointestinal [GI] tract, liver, and rapidly perfused tissues) and diffusion-limited (fat, blood/plasma, and slowly perfused tissues) rate equations. The blood was divided into plasma and erythrocytes. Cytochrome P450-mediated metabolism was accounted for in the liver and carboxylesterase (CaE)-mediated metabolism in plasma and liver. Serial blood, brain, and fat samples were taken for DLT analysis for up to 48 h after adult rats received 2 or 10 mg DLT/kg po. Hepatic biotransformation accounted for approximately 78% of these administered doses. Plasma CaEs accounted for biotransformation of approximately 8% of each dosage. Refined PBPK model forecasts compared favorably to the 2- and 10-mg/kg po blood, plasma, brain, and fat DLT profiles, as well as profiles subsequently obtained from adult rats given 1 mg/kg iv. DLT kinetic profiles extracted from published reports of oral and iv experiments were also used for verification of the model's simulations. There was generally good agreement in most instances between predicted and the limited amount of empirical data. It became clear from our modeling efforts that there is considerably more to be learned about processes that govern GI absorption and exsorption, transport, binding, brain uptake and egress, fat deposition, and systemic elimination of DLT and other pyrethroids. The current model can serve as a foundation for construction of models for other pyrethroids and can be improved as more definitive information on DLT kinetic processes becomes available.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831841     DOI: 10.1093/toxsci/kfl056

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  12 in total

1.  Use of partition coefficients in flow-limited physiologically-based pharmacokinetic modeling.

Authors:  Matthew D Thompson; Daniel A Beard; Fan Wu
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-05-26       Impact factor: 2.745

2.  Studying permethrin exposure in flight attendants using a physiologically based pharmacokinetic model.

Authors:  Binnian Wei; Sastry S Isukapalli; Clifford P Weisel
Journal:  J Expo Sci Environ Epidemiol       Date:  2013-03-06       Impact factor: 5.563

3.  Using physiologically-based pharmacokinetic models to incorporate chemical and non-chemical stressors into cumulative risk assessment: a case study of pesticide exposures.

Authors:  Susan C Wason; Thomas J Smith; Melissa J Perry; Jonathan I Levy
Journal:  Int J Environ Res Public Health       Date:  2012-05-22       Impact factor: 3.390

Review 4.  Effects of pyrethroids on brain development and behavior: Deltamethrin.

Authors:  Emily M Pitzer; Michael T Williams; Charles V Vorhees
Journal:  Neurotoxicol Teratol       Date:  2021-04-20       Impact factor: 4.071

5.  Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies.

Authors:  Kun Liao; Na Tang; Qiang Liu; Jing Xu
Journal:  AAPS PharmSciTech       Date:  2021-01-27       Impact factor: 4.026

6.  Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in Humans.

Authors:  Pankajini Mallick; Marjory Moreau; Gina Song; Alina Y Efremenko; Salil N Pendse; Moire R Creek; Thomas G Osimitz; Ronald N Hines; Paul Hinderliter; Harvey J Clewell; Brian G Lake; Miyoung Yoon
Journal:  Toxicol Sci       Date:  2020-01-01       Impact factor: 4.849

7.  Transcriptional response of rat frontal cortex following acute in vivo exposure to the pyrethroid insecticides permethrin and deltamethrin.

Authors:  Joshua A Harrill; Zhen Li; Fred A Wright; Nicholas M Radio; William R Mundy; Rogelio Tornero-Velez; Kevin M Crofton
Journal:  BMC Genomics       Date:  2008-11-18       Impact factor: 3.969

8.  Evidence for dose-additive effects of pyrethroids on motor activity in rats.

Authors:  Marcelo J Wolansky; Chris Gennings; Michael J DeVito; Kevin M Crofton
Journal:  Environ Health Perspect       Date:  2009-06-08       Impact factor: 9.031

9.  A novel toxicokinetic modeling of cypermethrin and permethrin and their metabolites in humans for dose reconstruction from biomarker data.

Authors:  Jonathan Côté; Yvette Bonvalot; Gaétan Carrier; Caroline Lapointe; Uwe Fuhr; Dorota Tomalik-Scharte; Bertil Wachall; Michèle Bouchard
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

10.  Addressing Early Life Sensitivity Using Physiologically Based Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation.

Authors:  Miyoung Yoon; Harvey J Clewell
Journal:  Toxicol Res       Date:  2016-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.